Advanced or Metastatic Solid Tumor Completed Phase 1 Trials for Rogaratinib (DB15078)

Also known as: Advanced / Metastatic Solid Tumor / Advanced/Metastatic Solid Tumor / Advanced and Metastatic Solid Tumor / Metastatic and Advanced Solid Tumors / Advanced and/or Metastatic Solid Tumors / Advanced or Metastatic Solid Tumors / Advanced / Metastatic Solid Tumors / Advanced/ Metastatic Solid Tumors / Advanced/Metastatic Solid Tumors

IndicationStatusPhase
DBCOND0109909 (Advanced or Metastatic Solid Tumor)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03517956Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid TumorsTreatment